All stock lists
Barinthus Biotherapeutics plc. (NASDAQ:BRNS)
US · Delayed Price · Currency is USD
0.74-0.02 (-2.49%)
Insider Score
––Not scored
BRNS Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BRNS analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on BRNS that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering BRNS
No firm covering BRNS has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.